House Select Committee on Health Reform Drug Pricing and Accessibility

Policy
August 4, 2022
  • Twitter
  • Facebook
  • Google+
  • Linkedin
2. Drug Prices and Accessibility Panel 1: Overview of Prescription Drug Coverage and Reimbursement Antonio Ciaccia, antonio@3axisadvisors.com Background: CEO, 46brooklyn; President, 3 Axis Advisors Robert Popovian Debbie Garza, dgarza@texaspharmacy.org Background: CEO, Texas Pharmacy Association Melody Schrader, Pharmaceutical Care Management Association (PCMA) Leigh Purvis Background: Health Service Researcher, AARP's Public Policy Institute Panel 2: Ensuring Access to Prescription Drugs Sharon Lamberton, slamberton@phrma.org Background: Vice President of Policy, PhRMA Blake Hutson, Texas Association of Health Plans (TAHP) Madelaine Feldman, MD, madelainefeldman@gmail.com Background: Rheumatologist; President, Coalition of State Rheumatology Organizations; Chair, Alliance for Safe Biologic Medicines Darin Okuda, MD, darin.okuda@utsouthwestern.edu Background: Neurologist; Director, Multiple Scleros

Subscribe to gain full access to all of our must-have reports and videos

OR

Log in